跳至主要内容
临床试验/NCT07253350
NCT07253350招募中不适用

Effectiveness of Endorotor PED® System Versus Conventional Endoscopic Techniques for the Management of Walled-off Pancreatic Necrosis in Acute Necrotizing Pancreatitis: Randomized Single-blinded Controlled Superiority Trial and Cost-utility Analysis

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2026年1月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
64
试验地点
1
主要终点
evaluate the effectiveness of the Endorotor PED® device versus conventional technique for the endoscopic management of symptomatic walled-off necrosis during necrotizing acute pancreatitis.

研究概览

简要总结

This is a national single-blinded prospective multicenter randomized (1:1) controlled trial, with two parallel arms, using a PROBE methodology, including patients with complicated acute necrotizing pancreatitis who require DEN of WON collection after endoscopic drainage. We will compare 2 groups: conventional DEN and DEN with Endorotor®. The study will be offered to all consecutive patients fulfilling the eligibility criteria after endoscopic drainage for WON. Since the time between drainage and the first necrosectomy session is usually at least 48 hours a period of at least 24h will be allowed for the patient to consider options to participate or not. Information and collection of informed consent will be done by an investigating physician.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age≥18years
  • CT scan less than 7 days old
  • Hospitalized for acute necrotizing pancreatitis, whatever the cause, and who have undergone drainage of pancreatic collections for the following indications according to the revised Atlanta criteria (infection, organ compression, persistent organ failure)
  • Have need for at least one DEN session despite endoscopic drainage (persistence of clinical symptoms or sepsis >48h after drainage with collection still visible)

排除标准

  • No endoscopic drainage in place for the management of WON
  • Have already had a DEN session (endoscopic or else) before screening for inclusion
  • Life-expectancy < 1year (advanced cancer, etc)
  • Known haemostasis disorder (chronic thrombocytopenia, haemophilia, etc.)
  • Pregnant or breastfeeding woman
  • Subject deprived of freedom, subject under a legal protective measure
  • Non-affiliation to a social security regimen or CMU
  • Patient or person of confidence (if present at the time of inclusion) opposing the patient's participation in research
  • Subject already involved in another interventional clinical research

研究组 & 干预措施

Endorotor Group

Experimental

DEN will be performed with Endorotor 3.2 or ENDOROTOR PED® system depending on the position of cystoenterostomy.

干预措施: Endorotor Group (Device)

Conventional group

Active Comparator

DEN is performed conventionally with abundant lavage and mechanical debridement using a non-dedicated material (diathermic loop, polypectomy or Dormia basket) to catch pieces of necrosis

干预措施: Conventional group (Other)

结局指标

主要结局

evaluate the effectiveness of the Endorotor PED® device versus conventional technique for the endoscopic management of symptomatic walled-off necrosis during necrotizing acute pancreatitis.

时间窗: 5 month

The effectiveness of the operative approach (Endorotor 3.2/PED® or conventional technique) will be assessed by the period in days between the first DEN session and the confirmed complete necrosis resolution.

次要结局

  • Number of days of antibiotic treatment(4 month)
  • number of death(10 month)
  • number of new-onset multiple organ failure(10 month)
  • number of visceral perforation(10 month)
  • number of arterial perforation(10 month)
  • number of pancreatic-cutaneous fistulas(10 month)
  • number of sepsis(10 month)
  • number of abscess(4 month)
  • number of Bleeding of any severity(4 month)
  • number of Need for surgery (video-assisted retroperitoneal debridement or open surgery)(4 month)
  • number of Need for "multigate" strategy with the installation of a percutaneous drain(4 month)
  • time to total recovery of acute pancreatitis(16 month)
  • Total time of all DEN sessions in minutes(4 month)
  • Total number of DEN sessions(4 month)
  • operative difficulty of DEN assessed by endoscopists(4 month)
  • number of issues with Endorotor PED® device(4 month)
  • Number of days of hospitalization: In intensive care unit(16 month)
  • Number of days of hospitalization: In conventional unit(16 month)
  • Number of days of hospitalization in rehabilitation unit(16 month)
  • quality of life of patients during and after hospitalization(16 month)
  • Total hospital costs in acute care per patient Endorotor(16 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验